Rothblatt Martine A

United Therapeutics Corporation · Chairperson & CEO

Rothblatt Martine A is listed in filings as Chairperson & CEO at United Therapeutics Corporation. This profile follows SEC Form 4 activity through Jun 24, 2026, including sale activity and purchase activity. Recent filings connect the profile to United Therapeutics Corporation (UTHR). The current snapshot covers public activity from May 27, 2026 to Jun 24, 2026. Reported amounts are shown as $146.3K to $1.7M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

History Trades

CompanyValueActionPriceCurrent Price
United Therapeutics CorpUTHR$919k1.7k sharesSellJun 4, 2026$548.26$535.83
United Therapeutics CorpUTHR$835k1.5k sharesSellJun 4, 2026$547.53$535.83
United Therapeutics CorpUTHR$656k1.2k sharesSellJun 4, 2026$546.14$535.83
United Therapeutics CorpUTHR$647k1.2k sharesSellJun 4, 2026$545.18$535.83
United Therapeutics CorpUTHR$800k1.5k sharesSellJun 4, 2026$544.24$535.83
United Therapeutics CorpUTHR$215k396 sharesSellJun 4, 2026$543.11$535.83
United Therapeutics CorpUTHR$61k112 sharesSellJun 4, 2026$542.50$535.83
United Therapeutics CorpUTHR$256k473 sharesSellJun 4, 2026$541.08$535.83
United Therapeutics CorpUTHR$65k120 sharesSellJun 4, 2026$539.51$535.83
United Therapeutics CorpUTHR$935k1.6k sharesSellMay 26, 2026$577.03$535.83
United Therapeutics CorpUTHR$864k1.5k sharesBuyMay 26, 2026$575.96$535.83
United Therapeutics CorpUTHR$590k1k sharesSellMay 26, 2026$577.97$535.83
United Therapeutics CorpUTHR$545k958 sharesSellMay 26, 2026$568.63$535.83
United Therapeutics CorpUTHR$1M2.5k sharesSellMay 27, 2026$576.23$535.83
Showing 51-64 of 64